High Activity 177Lu-PSMA Therapy Of Metastatic Castration-resistant Prostate Cancer

被引：0
|
作者：
Happel, C. [1 ]
Kranert, W. T. [1 ]
Bockisch, B. [1 ]
Groener, D. [1 ]
Davis, K. H. [1 ]
Wichert, J. [1 ]
Stefanova, M. [1 ]
Gruenwald, F. [1 ]
Sabet, A. [1 ]
机构：
[1] Univ Med Ctr Frankfurt, Dept Nucl Med, Frankfurt, Germany
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2019年 / 46卷 / SUPPL 1期
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
EP-0580
引用
收藏
页码：S647 / S648
页数：2
相关论文
共 50 条
  • [1] 177Lu-PSMA Therapy in Metastatic Castration-Resistant Prostate Cancer
    Sanli, Yasemin
    Simsek, Duygu Has
    Sanli, Oner
    Subramaniam, Rathan M.
    Kendi, Ayse Tuba
    BIOMEDICINES, 2021, 9 (04)
  • [2] Perspective on 177Lu-PSMA Therapy for Metastatic Castration-Resistant Prostate Cancer
    Kwekkeboom, Dik
    JOURNAL OF NUCLEAR MEDICINE, 2016, 57 (07) : 1002 - 1003
  • [3] 177Lu-PSMA for Extended Treatment of Metastatic Castration-Resistant Prostate Cancer
    Derlin, Thorsten
    Widjaja, Liam
    Werner, Rudolf A.
    Bengel, Frank M.
    JOURNAL OF NUCLEAR MEDICINE, 2023, 64 (01) : 54 - 58
  • [4] 177Lu-PSMA and 177Lu-DOTATATE Therapy in a Patient With Metastatic Castration-Resistant Prostate Cancer and Neuroendocrine Differentiation
    Assadi, Majid
    Pirayesh, Elahe
    Rekabpour, Seyed Javad
    Zohrabi, Farshad
    Jafari, Esmail
    Nabipour, Iraj
    Esmaili, Abdolhamid
    Amini, Abdullatif
    Ahmadzadehfar, Hojjat
    CLINICAL NUCLEAR MEDICINE, 2019, 44 (12) : 978 - 980
  • [5] Predicting outcomes after 177Lu-PSMA therapy in castration-resistant prostate cancer
    Hindie, Elif
    LANCET ONCOLOGY, 2021, 22 (10): : E425 - E425
  • [6] Advances in 177Lu-PSMA and 225Ac-PSMA Radionuclide Therapy for Metastatic Castration-Resistant Prostate Cancer
    Ling, Sui Wai
    de Blois, Erik
    Hooijman, Eline
    van der Veldt, Astrid
    Brabander, Tessa
    PHARMACEUTICS, 2022, 14 (10)
  • [7] Treatment efficacy and safety of 177Lu-PSMA Radioligand Therapy in Octogenarians with metastatic castration-resistant prostate cancer
    Langbein, T.
    Retz, M.
    D'Alessandria, C.
    Grigorascu, S.
    Hansen, K.
    Wester, H.
    Gschwend, J.
    Weber, W.
    Eiber, M.
    Tauber, R.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2022, 49 (SUPPL 1) : S132 - S133
  • [8] Metastatic extent predicts survival as patients with metastatic castration-resistant prostate cancer are treated with 177Lu-PSMA radioligand therapy
    von Eyben, Finn Edler
    Kulkarni, Harshad R.
    Baum, Richard P.
    THERANOSTICS, 2020, 10 (11): : 4900 - 4902
  • [9] Exceptional 4-year response to 177Lu-PSMA radioligand therapy in metastatic castration-resistant prostate cancer
    Gafita, Andrei
    Wang, Hui
    Tauber, Robert
    D'Alessandria, Calogero
    Weber, Wolfgang A.
    Eiber, Matthias
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2019, 46 (10) : 2212 - 2213
  • [10] 177Lu-PSMA Therapy for Metastatic Castration-Resistant Prostate Cancer: A Mini-Review of State-of-the-Art
    AlSadi, Rahaf
    Bouhali, Othmane
    Dewji, Shaheen
    Djekidel, Mehdi
    ONCOLOGIST, 2022, 27 (12): : E957 - E966
12345